ABSTRACT Many heterogametic organisms adjust sex chromosome expression to accommodate differences in gene dosage. This requires selective recruitment of regulatory factors to the modulated chromosome. How these factors are localized to a chromosome with requisite accuracy is poorly understood. Drosophila melanogaster males increase expression from their single X chromosome. Identification of this chromosome involves cooperation between different classes of X-identity elements. The chromatin entry sites (CES) recruit a chromatin-modifying complex that spreads into nearby genes and increases expression. In addition, a family of satellite repeats that is enriched on the X chromosome, the 1.688 X repeats, promotes recruitment of the complex to nearby genes. The 1.688 X repeats and CES are dissimilar, and appear to operate through different mechanisms. Interestingly, the siRNA pathway and siRNA from a 1.688 X repeat also promote X recognition. We postulate that siRNA-dependent modification of 1.688 X chromatin contributes to recognition of nearby genes. In accord with this, we found enrichment of the siRNA effector Argonaute2 (Ago2) at some 1.688 X repeats. Mutations in several proteins that physically interact with Ago2, including the histone methyltransferase Su(var)3-9, enhance the lethality of males with defective X recognition. Su(var)3-9 deposits H3K9me2 on some 1.688 X repeats, and this mark is disrupted upon ectopic expression of 1.688 X siRNA. Furthermore, integration of 1.688 X DNA on an autosome induces local H3K9me2 deposition, but enhances expression of nearby genes in a siRNA-dependent manner. Our findings are consistent with a model in which siRNA-directed modification of 1.688 X chromatin contributes to recognition of the male X chromosome for dosage compensation.
M
ALES of many species carry one X chromosome and a gene-poor Y chromosome. Hemizygosity of the male X chromosome produces a potentially lethal imbalance in the ratio of X to autosomal gene products. This imbalance is corrected by a process known as dosage compensation, a specialized type of gene regulation that modulates expression of an entire chromosome. Different strategies to achieve dosage compensation have evolved independently. In Drosophila melanogaster, males increase X-linked gene expression by approximately twofold (Lucchesi et al. 2005) . This involves the activity of the Male Specific Lethal (MSL) complex. The MSL complex is recruited to active genes on the X chromosome, where it modifies chromatin to increase expression (Lucchesi and Kuroda 2015) . The MSL complex contains five proteins, Male-Specific Lethal-1, -2, and -3 (MSL1, -2, -3), Maleless (MLE), and Males absent on the first (MOF) (reviewed in Koya and Meller 2011) . Enhanced transcription by the MSL complex is associated with H4K16 acetylation by MOF (Akhtar and Becker 2000; Smith et al. 2000) . H4K16 acetylation decompacts chromatin, and this may enhance transcriptional elongation of X-linked genes (Shogren-Knaak et al. 2006; Larschan et al. 2011) .
The MSL complex also contains one of two long noncoding RNA on the X (roX1, 2) transcripts (Quinn et al. 2014) . While elimination of any one of the MSL proteins is lethal to males, roX1 and roX2 are redundant for compensation. Mutation of both roX genes leads to mislocalization of the MSL proteins to ectopic autosomal sites in male larvae (Meller and Rattner 2002; Deng and Meller 2006) . X-linked gene expression is reduced in these males, as is survival to adulthood. Both roX genes are located on the X chromosome, and both overlap chromatin entry sites (CES)-specialized sites with increased affinity for the MSL complex (Kelley et al. 1999; Alekseyenko et al. 2008; Straub et al. 2008) .
Although much is known about the role of MSL complex in dosage compensation, how this complex selectively targets the X chromosome is poorly understood. Recognition and binding to X chromatin is believed to be a two-step process. Initial recruitment of the MSL complex to CES is followed by spreading into nearby transcribed genes (Gelbart and Kuroda 2009) . Contained within the CES are motifs called MSL recognition elements (MREs) (Alekseyenko et al. 2008; Straub et al. 2008) . MREs are 21-bp GA-rich motifs that bind chromatin-linked adaptor for MSL protein (CLAMP)-a zinc finger protein that is essential for MSL recruitment (Soruco et al. 2013) . Spreading into nearby active genes is supported by interaction of MSL3 with the cotranscriptional H3K36me3 mark (Kind and Akhtar 2007; Larschan et al. 2007; Sural et al. 2008) . These mechanisms describe local recruitment of the MSL complex, but fail to explain how the MSL complex specifically targets the X chromosome. H3K36me3 is found on active genes throughout the genome, and MREs are only modestly enriched on the X chromosome. Furthermore, CLAMP binds MREs throughout the genome, but only recruits the MSL complex to X-linked CES (Alekseyenko et al. 2008; Soruco et al. 2013) . We conclude that additional mechanisms must distinguish X and autosomal chromatin.
X-localization is disrupted in roX1 roX2 males, making them a sensitized genetic background that can be used to identify additional factors contributing to X recognition. Using this strategy, our laboratory demonstrated a role for the siRNA pathway in recognition of the X chromosome (Menon and Meller 2012; Menon et al. 2014) . A likely source of siRNA is a family of repeats that is near exclusive to the X chromosome. These are the AT-rich, 359-bp 1.688 X satellite repeats, a clade of which is found in short, tandem arrays throughout X euchromatin (Hsieh and Brutlag 1979; Waring and Pollack 1987; DiBartolomeis et al. 1992; Gallach 2014) . Specific clusters are denoted by a superscript indicating cytological position. In support of the idea that 1.688 X repeats assist X recognition, ectopic production of siRNA from one repeat partially rescues roX1 roX2 males (Menon et al. 2014 ). 1.688 X repeats are often close to or within genes, leading to the idea that they function as "tuning knobs" for gene regulation (Kuhn et al. 2012) . In accord with these ideas, autosomal insertions of 1.688 X DNA enable recruitment of functional dosage compensation to nearby autosomal genes (Joshi and Meller 2017) . The 1.688 X repeats share no sequence identity with the CES, and appear to act in a genetically distinct manner (Joshi and Meller 2017) . The question of how 1.688 X DNA promotes compensation of nearby genes is thus of great interest. We pursued the idea that siRNA-directed modifications of chromatin at 1.688 X repeats link the repeats and the siRNA pathway to X recognition. Reduction of the siRNA-binding effector protein Argonaute2 (Ago2) enhances the lethality of partial loss of function roX1 roX2 mutations, and further reduces X-localization of MSL proteins (Menon and Meller 2012) . We hypothesized that an Ago2-containing complex might localize to and modify 1.688 X chromatin in otherwise wild-type flies. In accord with this idea, we find that Ago2 is enriched at 1.688 X repeats. Proteins interacting with Ago2 may also play a role in dosage compensation. To address this, we tested high confidence Ago2-binding proteins for genetic interactions with roX1 roX2, and found that mutations in several of these genes further reduced the survival of roX1 roX2 males. Of particular interest is the H3K9 methyltransferase Su (var)3-9, which is responsible for enrichment of H3K9me2 at a subset of 1.688 X repeats. H3K9me2 enrichment is disrupted upon ectopic expression of 1.688 X siRNA. Chromatin flanking an autosomal insertion of 1.688 X DNA is enriched for H3K9me2, and enrichment is enhanced by ectopic expression of 1.688 X siRNA. In contrast to the repressive nature of H3K9me2, we find that expression of autosomal genes close to the 1.688 X transgene is increased in male larvae, and further elevated by additional 1.688 X siRNA. These findings support the idea that X recognition and transcriptional upregulation by dosage compensation are distinct processes, and suggest that siRNA-dependent modification of chromatin in or near 1.688 X repeats contributes to X recognition in wild type flies. We propose that epigenetic modifications link the siRNA pathway, 1.688 X repeats on the X chromosome and X recognition.
Materials and Methods

Fly culture and genetics
Mutations Dcr1 Q1147X (BDSC #32066), Rm62 01086 (BDSC #11520), Fmr1 D113m (BDSC #67403), Su(var)3-9 1 (BDSC #6209), Su(var)3-9 2 (BDSC #6210), smg 1 (BDSC #5930), Taf11 1 (BDSC #65410), Taf11 5 (BDSC #65409), p53 5A-1-4 (BDSC #6815), p53 11-1B-1 (BDSC #6816), foxo D94 (BDSC #42220), PIG-S e00272 (BDSC #17833), bel L4740 (BDSC #10222), bel 6 (BDSC #4024), barr L305 (BDSC #4402), SmD1 EY01516 (BDSC #15514), vig C274 (BDSC #16323), Ago1 k08121 (BDSC #10772), aub QC42 (BDSC #4968), piwi 06843 (BDSC #12225), Su(var)2-10 2 (BDSC #6235), egg MB00702 (BDSC #22876), G9a MB11975 (BDSC #29933), P{EPgy2} 09821 (BDSC #16954), P{EPgy2} 15840 (BDSC #21163), and FLAG.HA.Ago2 (BDSC #33242)were obtained from the Bloomington Drosophila Stock Center. Ago2 414 (Kyoto #109027) was obtained from the Kyoto Stock Center. Su(var)3-7 14 was a gift from Dr. P. Spierer (Seum et al. 2002) . ocm 166 was a gift from Dr. R. Kelley. DDsRedDupSET (upSET in Figure 2 ) was a gift from Dr. M. Kuroda (McElroy et al. 2017) . To minimize genetic background effects all mutations were outcrossed for five generations using a nearby marked P-element (unmarked mutations) or the laboratory reference yw strain (mutations marked with w + or y + ). Stocks were constructed with outcrossed, rebalanced chromosomes, and a reference Y-chromosome (Menon and Meller 2009 ). All mutations were confirmed by phenotype or PCR. Mating schemes to determine the effect of Ago2-interactors on dosage compensation are presented in Supplemental Material, Figure  S1 . Each test scored 1000 flies and was performed in triplicate. To express 1.688 3F siRNA in a Su(var)3-9 2/2 mutant background, we generated [hp1. Lee and Carthew 2003) . Although siRNA accumulates to abnormally high levels in larvae expressing [hp1.688 3F ], the siRNAs produced appear similar to those isolated from wild type embryos (Menon et al. 2014) Tissue collection and chromatin preparation Embryo collection and chromatin preparation was as previously described (Koya and Meller 2015) . Briefly, 0.5 g of 0-12 hr embryos were collected on molasses plates with yeast. Embryos were dechorionated for 2.5 min in bleach, cross-linked in 50 mM HEPES, 1 mM EDTA, 0.5 mM EGTA, 100 mM NaCl, 1% formaldehyde with heptane for 20 min. Cross-linking was quenched with 125 mM glycine, 0.01% Triton X-100, 13 PBS for 30 min. Embryos were washed with 10 mM HEPES, 200 mM NaCl, 1 mM EDTA, 0.5 mM EGTA and 0.01% Triton X-100, and suspended in 2.5 ml of 10 mM HEPES, 1 mM EDTA, 0.5 mM EGTA, 0.1% Nadeoxycholate and 0.02% Na-azide for sonication. Sonication, performed on ice at 35% amplitude, 30 sec on, 59 sec off for a total time 15 min using a Fischer Scientific Model FB505 sonicator, produced 300-600 bp fragments. Chromatin was clarified by centrifuging at 13,000 rpm for 15 min, diluted 1:1 with 23 RIPA buffer [2% Triton X-100, 0.2% Na-deoxycholate, 0.2% SDS, 280 mM NaCl, 20 mM TrisHCl pH 8.0, 2 mM EDTA, 0.02% Na-azide, 2 mM DMSF with complete protease inhibitor (Roche)]. Chromatin solution (5.5 ml) was preabsorbed by incubation at 4°for 30 min with 55 ml of blocked Pierce Protein A agarose beads (Catalog #20333) and aliquots stored at 280°.
For larval chromatin, a modified protocol from Kuzu et al. (2016) was used. 150 larvae were frozen in liquid N 2 and ground in a chilled mortar. The powder was transferred to a cooled 15 ml Dounce and homogenized with a loose pestle (10 strokes) and a tight pestle (15 strokes) in 10 ml PBS with protease inhibitor. Homogenate was made to 40 ml with PBS, cross-linked with 1% formaldehyde for 20 min, and quenched with 125 mM glycine for 30 min. Cross-linked material was pelleted, washed once with wash buffer A (10 mM Hepes pH 7.6, 10 mM EDTA, 0.5 mM EGTA, 0.25% Triton X-100, protease inhibitor and 0.2 mM PMSF), once with wash buffer B (10 mM Hepes pH 7.6, 100 mM NaCl, 1 mM EDTA, 0.5 mM EGTA, 1% Triton X-100, protease inhibitor and 0.2 mM PMSF), and three times with TE wash buffer (10 mM Tris pH 8.0, 1 mM EDTA, 0.01% SDS, protease inhibitor, and 0.2 mM PMSF). The pellet was resuspended in 2 ml pre-RIPA buffer (0.1% SDS, 10 mM TrisHCl, 1 mM EDTA, protease inhibitor, and 0.2 mM PMSF). Sonication was performed at settings described above for 2 min. Sonicated samples were diluted with 1% Triton X-100, 0.1% Na-deoxycholate, and 140 mM NaCl, centrifuged at 1500 3 g to clarify, aliquoted, and stored at 280°.
Chromatin immunoprecipitation
Chromatin (75 mg) was incubated overnight at 4°with 4 ml anti-H3K9me2 (ab1220; Abcam) or 8 ml anti-H3K9me3 (ab8898; Abcam), clarified by centrifugation at 14,000 rpm for 5 min, and supernatants transferred to tubes containing 40 ml blocked Pierce Protein A agarose beads (Catalog #20333) and incubated 4 hr at 4°. Following washing, reverse cross-linking, organic extraction, and precipitation, DNA was suspended in 50 ml distilled water.
ChIP-qPCR
Duplicate 20 ml reactions consisting of 2 ml DNA, 10 ml BioRad iTaq (#172-5101), and primers were amplified using an Mx3000P Real-Time PCR system (Stratagene). SE was derived from the mean Ct values of biological replicates. Quantitative PCR (qPCR) analysis was previously described (Koya and Meller 2015) . Each ChIP pull down was validated. For H3K9me2, primers in an H3K9me2-enriched region of the third chromosome, and dmn (DCTN2-p50) served as positive and negative controls. ChIP primers are presented in Table  S1 . Primer specificity for 1.688 X repeats was ensured by anchoring one primer in flanking unique sequence (1.688 1A , 1.688 3C , 1.688 4A , and 1.688 7E ) or by designing primers to unique sequences within repeats and testing with genomic DNA from a strain deleted for the repeat cluster (1.688 3F and 1.688 7F ; see Menon et al. 2014) . Primer efficiencies were determined using MxPro qPCR software. Repeat copy number is normalized by expressing enrichment as percent input.
Protein isolation from embryos
Embryos (0-12 hr; 50 mg) were homogenized in 250 ml RIPA buffer on ice. Homogenate was passed through a 26 gauge needle 10-12 times to shear DNA. Particulate matter was removed by centrifugation, and supernatant was mixed with an equal volume of 23 SDS sample buffer and boiled for 5 min before separation on a 15% SDS polyacrylamide gel.
Protein blotting
Polyacrylamide gels were equilibrated in transfer buffer (48 mM Tris, 39 mM glycine, 1.3 mM SDS, 20% methanol) for 20 min. A polyvinylidene difluoride (PVDF) membrane was activated in 100% methanol for 1 min. Filter paper and activated PVDF membranes were saturated in transfer buffer and proteins transferred using a Trans-Blot SD Semi-Dry Transfer Cell (Bio-Rad). The membrane was washed in TBST (10 mM Tris-Cl, 200 mM NaCl, 0.1% Tween 20, pH 7.5), blocked in 5% bovine serum albumin, and probed overnight at 4°using 1:2000 mouse anti-H3K9me2 diluted in blocking solution (ab1220; Abcam) or 1:4000 goat antitubulin (E7; Developmental Studies Hydrinoma Bank). After washing with TBST, the membrane was incubated with alkaline-phosphatase-conjugated secondary antibodies (A3562, goat anti-mouse; Sigma, or A4062, rabbit anti-goat; Sigma), washed and developed in 100 mM diethanolamine, 100 mM NaCl, 5 mM MgCl 2 , pH 9.5 containing 33 mg/ml nitroblue tetrazolium (NBT) and 165 mg/ml 5-bromo-4-chloro-3-indolyl phosphate (BCIP). Signals were quantified by ImageJ.
Quantitative RT-PCR
Total RNA was isolated from 50 third instar male larvae or 100 mg dechorionated embryos using Trizol reagent (Invitrogen) as previously described (Koya and Meller 2015) . RNA (1 mg) was reverse-transcribed using random hexamers and ImProm-II reverse transcriptase (Promega). Duplicate reactions were amplified using iTaq Universal SYBR Green Supermix (Bio-Rad) with an Mx3000P Real-Time PCR system (Stratagene). Primers are in Table S1 . For determining relative transcript abundance, values were normalized to dmn. To calculate fold change, values were normalized to dmn and to a reference strain. Expression was calculated using the efficiency corrected comparative quantification method (Pfaffl 2001) .
Data availability
The authors state that all data necessary for confirming the conclusions presented in the manuscript are represented fully within the manuscript. Strains and materials used in this study are available upon request. Supplemental material available at Figshare: https://doi.org/10.25386/genetics.6083165.
Results
Ago2 localizes at 1.688 X repeats
We took advantage of the resolution of ChIP and a FLAGtagged Ago2 transgene to determine if Ago2 localizes to 1.688 X repeats. FLAG-Ago2 was first tested for rescue of the dosage compensation function of Ago2. Males with the partial loss of function roX1 ex40 roX2D chromosome have high survival, as do Ago2 2/2 flies, but synthetic lethality is observed in roX1 ex40 roX2D/Y; Ago2 2/2 males (Menon and Meller 2012) . One copy of a FLAG-Ago2 transgene rescues these males, demonstrating that the FLAG tag does not disrupt the dosage compensation function of Ago2 ( Figure 1A ). Chromatin from FLAG-Ago2; Ago 2/2 embryos, and from a reference strain lacking the FLAG-Ago2 transgene, was immunoprecipitated with anti-FLAG antibodies and enrichment ; FLAG-Ago2 (black) embryos was precipitated with anti-FLAG antibody. Enrichment normalized to input is shown. The Hsp70 promoter displays enrichment, but a control region in dmn does not. (C) FLAGAgo2 enrichment is detected at several 1.688 X repeats (gray arrowheads). Approximately 100 copies of the 1.688 1A repeats are situated between tyn and CG3038. The 1.688 3C repeats are within a large kirre intron (splicing indicated by diagonal lines). Primers, indexed by gene and amplicon number, are presented in Table S1 . Amplicon numbers, constant throughout this study, denote regions in selected repeats and flanking regions as indicated on gene models. In (C) only two amplicons per repeat, one including the repeats and in an adjacent region, were analyzed. determined by qPCR. FLAG-Ago2 was enriched at the Hsp70 promoter-a site known to bind Ago2 (Cernilogar et al. 2011) (Figure 1B) . In contrast, a control region in the dmn gene displayed no enrichment. We then examined FLAG-Ago2 enrichment at a panel of six representative 1.688 X repeat clusters that differ in location and environment (within, near or far from protein coding genes), transcription level, and sequence (Table 1) . Interestingly, five of these show enrichment of FLAG-Ago2 over the repeats, but little or no enrichment in flanking regions ( Figure 1C ). We conclude that Ago2 localizes at many 1.688 X repeats, a finding that is consistent with involvement of Ago2 in siRNA-directed recruitment of chromatin modification at or around these regions.
An Ago2-interaction network that participates in dosage compensation
Argonaute proteins in the RNA induced transcriptional silencing (RITS) complexes of Schizosaccharomyces pombe, and plants recruit chromatin modifiers to nascent transcripts (reviewed in Meller et al. 2015) . To explore the possibility of Ago2-interacting proteins participating in X chromosome recognition, we screened genes in an Ago2-interaction network for genetic interaction with roX1 roX2. A map of high probability Ago2-interactors was created using BioGRID (Stark et al. 2006) , and esyN (Bean et al. 2014) (Figure 2A ; see File S2 for inclusion criteria). Members of this network were examined for genetic interactions with the partial loss of function roX1 ex33 roX2D X chromosome. roX1 ex33 roX2D males display partial mislocalization of MSL proteins and eclose at 20% of normal levels . Reduction of proteins that participate in X recognition further disrupts X localization and enhances roX1 ex33 roX2D male lethality (Menon and Meller 2012) . Females are fully viable and fertile when the roX genes are mutated. roX1 ex33 roX2D females were mated to males that were heterozygous for a mutation in the gene being tested ( Figure S1A ). All sons are roX1 ex33 roX2D/Y, and heterozygous (experimental) or wild type (control) for the gene of interest. A reduction in normalized survival (experimental/control) reveals enhancement of roX1 roX2 male lethality (Figure 2 , B and C). Daughters, which do not dosage compensate and are heterozygous for roX1 ex33 roX2D, do not display altered survival upon mutation of Ago2-interacting genes. As G9a is located on the X chromosome, a modified strategy to test this gene is presented in Figure S1B .
Normalized survival of roX1 ex33 roX2D males with mutations in the Ago2-interaction network is presented in Figure  2B . Genes displaying significant interactions are noted by pink symbols, and those showing no interaction are blue in Figure 2A . We confirmed a previously identified siRNAprocessing subnetwork containing Dcr2, Elp1, and loqs (Figure 2A , dotted line; Menon and Meller 2012) . The present study identified several additional Ago2-interactors, including a potential chromatin-modifying subnetwork containing Dcr1, Fmr1, Rm62, and the histone methyltransferase 857,647-3,858,186 4,070,631-4,071,316 8,369,270-8,369,783 8,530,749-8,531,260 Copy number The copy number at some positions differed between the laboratory reference strain and the genomic scaffold (see File S1). Similarity to 1.688 3F was determined by BLAST alignment of a 359 bp monomer. EST abundance is estimated from Flybase assignments. RNA polII enrichment is derived from ChIP-seq of 6-8 hr mesoderm (Monfort et al. 2017 ).
a Quantitative RT-PCR (qRT PCR) is normalized to repeat copy number (see Figure S4 ).
1.688 X Chromatin Modification by siRNASu(var)3-9 (green, Figure 2A ). Su(var)3-9 deposits H3K9me2 and acts with Rm62 to resilence active chromatin (Boeke et al. 2011) . Additional chromatin modifiers and genes in other small RNA pathways were also tested ( Figure 2C) . A previous study found no interaction between roX1 ex33 roX2D and the piRNA pathway genes aub and piwi, or the miRNA pathway gene Ago1, a finding replicated here (Menon and Meller 2012) . Since our findings point toward involvement of chromatin modifiers, we tested the chromatin regulatory factor Su(var)2-10 and two additional H3K9 methyltransferases, eggless (egg), and G9a ( Figure 2C ). None of these modified roX1 ex33 roX2D survival. Mutations in Su(var)3-7, important for heterochromatin formation, and upSET, which maintains heterochromatin and H3K9me2 levels, enhance roX1 ex33 roX2D male lethality (Spierer et al. 2008; McElroy et al. 2017) . Over compensating males (ocm) has an unusual dosage compensation phenotype as mutations in ocm rescue males with insufficient MSL activity, suggesting that it might act as a governor of activation (Lim and Kelley 2013) . Interestingly, mutation of ocm significantly increased the survival of roX1 ex33 roX2D males, supporting the idea that ocm normally restrains activation. The P{EPgy2} 09821 and P{EPgy2} 15840 strains, used to outcross Su(var)3-9 and barr mutants, display no interaction and serve as controls for genetic background. Taken together, these findings suggest that several genes that deposit H3K9me2, maintain this mark or participate in heterochromatin formation also contribute to X chromosome dosage compensation. At first glance these observations appear to be at odds with X chromosome hypertranscription-the ultimate consequence of X chromosome recognition.
Ectopically expressed 1.688 3F siRNA disrupts H3K9me2 patterns Previous studies found that ectopically produced 1.688 3F siRNA partially rescues roX1 roX2 males and increases X localization of the MSL complex (Menon et al. 2014) . The mechanism by which siRNA promotes X recognition is unknown. The discovery that insertion of 1.688 X DNA on an autosome enables functional compensation of nearby genes, and the enhancement of this effect by ectopic 1.688 3F siRNA, Figure 2 Ago2-interactors participate in dosage compensation. (A) Map of Ago2-interacting proteins. Genes displaying a genetic interaction with roX1 ex33 roX2D are pink, and those for which a significant interaction has not been detected are blue. Genes in gray are untested. A previously reported siRNA-producing subnetwork is denoted by the dotted line. A putative chromatin-modifying subnetwork identified in the present study is highlighted in green. Well-curated, high probability interactions from BioGRID and esyN are depicted by solid lines. See File S2 for inclusion criteria. (B) Mutations in many Ago2-interacting proteins reduce the recovery of roX1 ex33 roX2D males (black; roX1 ex33 roX2D/Y; mut/+ normalized to roX1 ex33 roX2D/Y; +/+). Females are unaffected (white; roX1 ex33 roX2D/++; mut/+ normalized to roX1 ex33 roX2D/++; +/+). (C) Additional controls and genes of interest. The mating strategy to test X-linked G9a is presented in Figure S1B . See Materials and Methods for upSET description. SEM is represented by error bars. Significance of #0.05 (*) and #0.001 (**) was determined using the Student's two sample t-test.
suggests siRNA action through cognate genomic regions (Joshi and Meller 2017) . In accord with this idea, an autosomal roX1 transgene also enables compensation of nearby genes, but is unaffected by 1.688 3F siRNA. To test the idea that 1.688 3F siRNA directs epigenetic modification of 1.688 X chromatin, we used ChIP to analyze chromatin in and around 1.688 X repeats on the X chromosome. ChIP-qPCR detected H3K9me2 enrichment in four out of six repeats (white bars, Figure 3 ). As H3K9me2 enrichment was not uniform, we considered additional factors that might determine this mark, and noted that only repeats showing evidence of transcription were enriched for H3K9me2, consistent with the idea of Ago2-dependent recruitment to nascent transcripts ( Figure  S4 ) (Verdel et al. 2004) . Upon ectopic expression of 1.688 3F siRNA a dramatic disruption of H3K9me2 was observed in and around 1.688 X repeats (black bars, Figure 3) Figure S2 ). We conclude that some 1.688 X repeats are enriched for H3K9me2, and that cognate siRNA broadly disrupts this mark within and several kb adjacent to 1.688 X DNA.
Su(var)3-9 deposits H3K9me2 at 1.688 X repeats
The identification of Su(var)3-9 as an indirect binding partner of Ago2, observation of a genetic interaction between roX1 roX2 and Su(var)3-9 and enrichment of H3K9me2 on some 1.688 X repeats suggested that Su(var)3-9 could be modifying 1.688 X repeats. D. melanogaster has three histone H3K9 methyltransferases, Su(var)3-9, eggless, and G9a, but only Su(var)3-9 mutations enhance the male lethality of roX1 roX2 (Figure 2 ; (Swaminathan et al. 2012) ). To determine if Su(var)3-9 is responsible for H3K9me2 at 1.688 X chromatin, we generated strains carrying Su(var)3-9 over a marked balancer, enabling selection of homozygous Su(var)3-9 mutant larvae. H3K9me2 enrichment is virtually eliminated over 1.688 X repeats in Su(var)3-9 2/2 mutants (Figure 4 , gray) and remains low in Su(var)3-9 2/2 larvae that express 1.688 3F siRNA (Figure 4, black) . This reveals that Su(var)3-9 deposits H3K9me2 at 1.688 X chromatin in wild type flies, and eliminates the possibility that a different methyltransferase is recruited to these regions following ectopic expression of 1.688 3F siRNA. Disruption of H3K9me2 upon expression of 1.688 3F siRNA thus reflects changes in the localization or activity of Su(var)3-9.
To determine how far from 1.688 X repeats the H3K9me2 disruption extends, regions 10-26 kb from repeats were examined. In each case, increased H3K9me2 was observed in embryos with ectopic 1.688 3F siRNA expression ( Figure  S3A ). This suggested the possibility of a global change in H3K9me2 levels. To address this we probed protein blots from wild type and 1.688 3F siRNA-expressing embryos to determine global levels of this modification, but found no Figure 3 Elevated 1.688 3F siRNA disrupts H3K9me2 enrichment around 1.688 X repeats. Chromatin from wild type embryos (white) and embryos ectopically producing 1.688 3F siRNA (black) was immunoprecipitated with antibody to H3K9me2. Enrichment over input was determined by quantitative PCR (qPCR). The SE of two biological replicates is shown. Amplicons correspond to numbered positions on the gene models above. Primers are presented in Table S1 .
evidence of a change in H3K9me2 ( Figure S3B ). As most H3K9me2 is found in heterochromatic regions that comprise .30% of the fly genome, the changes we detected in euchromatin may represent a negligible portion of the nuclear pool.
H3K9me2 is generally thought to be repressive, but compensation in flies occurs by increased expression of X-linked genes. To determine if changes in H3K9me2 enrichment correlate with changes in transcription, regions flanking 1.688 X repeats were examined in wild-type and 1.688 3F siRNA-expressing embryos. Consistent with H3K9me2 having a repressive effect, 1.688 3F siRNA decreases accumulation of mRNA, as well as noncoding intragenic and intronic regions, with elevated H3K9me2 (Figure S4 ). The apparent increase in 1.688 3F expression presumably originates from the transgene used to produce ectopic 1.688 3F siRNA. We detected dramatic reductions in messages immediately adjacent to 1.688 1A (tyn, G9a) and 1. 688 3F (ec, roX1) . In spite of a 90% reduction in ec transcript in embryos expressing 1.688 3F siRNA, adults do not display the rough eye ec phenotype. It is possible that ectopic 1.688 3F siRNA has a more pronounced effect in embryos, whose lack of differentiation may make them particularly susceptible to epigenetic disruption. Mature patterns of chromatin organization are established later in development, and these may be more resilient. To test this, we examined flanking genes in 1.688 3F siRNA-expressing third instar male larvae, and found that tyn, G9a, and ec regained wild-type transcript levels, and roX1 was largely restored ( Figure S4 ). The precise reason for the differences between embryos and larvae are uncertain, but restoration of normal gene expression by the third larval instar is consistent with the lack of phenotype in otherwise wild type flies that ectopically express 1.688 3F siRNA (Menon et al. 2014) .
The finding that animal age influenced response to ectopic siRNA prompted us to determine the time point at which H3K9me2 is established at 1.688 X repeats. A possible scenario is that this mark is placed before MSL localization, and acts in some way to guide X recognition. X-Localization of the MSL complex occurs 3 hr after egg laying (AEL) (Rastelli et al. 1995; Meller 2003) . We measured H3K9me2 enrichment at 1.688 3F in embryos before the MSL complex binds to the X (1.5-3 hr), during initial MSL recruitment (3-4 hr), and at 4-6 and 6-12 hr. In contrast to our prediction, H3K9me2 is first detected on 1.688 3F between 6 and 12 hr AEL, after X localization of the MSL complex has occurred ( Figure S5 ). We conclude that H3K9me2 at 1.688 X repeats is unlikely to guide initial X recognition, but may serve later to facilitate spreading of this mark or enforce the stability of X recognition. As the failure of dosage compensation only kills males at the end of the third instar, a mechanism that acts later in development would have considerable impact.
H3K9me2 is enriched at regions flanking autosomal 1.688 3F transgenes
One challenge of studying recruiting elements on the X chromosome is that the redundancy and proximity of these elements complicates interpretation. To overcome this, we tested autosomal integrations of 1.688 3F DNA or roX1 ( Figure  5A ) (Joshi and Meller 2017) . H3K9me2 ChIP was performed on chromatin from third instar male larvae with 1.688 3F (Figure 5B ) or roX1 ( Figure 5C ) on 2L (gray bars), and in the same genotypes with ectopic expression of 1.688 3F siRNA Figure 4 Su(var)3-9 deposits H3K9me2 at 1.688 X repeats. Chromatin from wild type male larvae (white), Su(var)3-9 1 /Su(var)3-9 1 male larvae (gray), and Su(var)3-9 1 /Su(var)3-9 1 males ectopically expressing 1.688 3F siRNA (black) was immunoprecipitated with antibody to H3K9me2. Enrichment normalized to input is shown. SE is derived from two biological replicates. See Materials and Methods for full genotypes and larval selection strategy.
(black bars). H3K9me2 within 5 kb of the integration site is not strongly enriched in control males, or in males with a roX1 transgene, but is striking elevated when 1.688 3F DNA is present. Consistent with our observations in embryos, ectopic 1.688 3F siRNA further elevated H3K9me2 near the 1.688 3F integration. This contrasts with negligible enrichment flanking the roX1 transgene ( Figure 5C ). For unknown reasons, enrichment over the integrated 1.688 3F DNA was itself undetectable. We conclude that autosomal insertion of 1.688 3F DNA makes flanking chromatin subject to siRNAinduced H3K9me2 deposition. Taken together, these studies support the idea that the 1.688 X repeats influence patterns of H3K9me2 nearby, but CES-containing roX1, with a different class of recruiting element, has little effect.
To determine the influence of 1.688 3F and roX1 on transcription of autosomal genes on 2L, we performed quantitative RT-PCR (qRT PCR) on total RNA from third instar male larvae of the genotypes described above. The 1.688 3F and roX1 integration site is in an intron of haf, .17 kb from the closest exon. We also examined RFeSP, CG33128, Eno (30, 89, and 142 kb from the insertion, respectively), and CG31778 and Rpl37A, 2.1 and 3.5 Mb distant ( Figure 5D ). The presence of 1.688 3F or roX1 integrations alone had no effect on the most distant genes, CG31778 and Rpl37A. A roX1 integration increased expression of haf 2.5-fold, more than expected from full compensation. This may reflect the fact that MSL recruitment to an autosomal roX1 transgene can overcome local, chromatin-based silencing (Kelley and Kuroda 2003) . Addition of 1.688 3F siRNA increased haf expression slightly, and similarly increased expression of CG33128 and Eno (light gray bars, Figure 5E) . A 1.688 3F insertion produced a fourfold increase in haf, and a slight increase in Eno, 141 kb from the integration site. But, upon expression of 1.688 3F siRNA, haf expression increased to eightfold wild-type levels, and CG33128 and Eno both increased to twofold wild-type levels, consistent with full compensation. We conclude that an autosomal insertion of 1.688 X DNA induces H3K9me2 deposition on flanking chromatin, but also increases expression of genes on 2L in a manner that is consistent with recruitment of the MSL complex. Both H3K9me2 enrichment and increased expression is enhanced by 1.688 3F siRNA, suggesting that X identification Chromatin from wild type third instar male larvae (white), larvae with 1.688 3F DNA at the landing site (gray), and larvae with 1.688 3F DNA at the landing site and ectopic 1.688 3F siRNA (black) was immunoprecipitated with antibody to H3K9me2. (C) H3K9me2 enrichment surrounding a roX1 insertion. Chromatin from wild type male third instar larvae (white), larvae with the roX1 insertion (gray), and with the roX1 insertion and ectopic 1.688 3F siRNA (black) was immunoprecipitated. Data are from two biological replicates and enrichment is normalized to input. (D) Portion of 2L showing relative location of CG33128, haf, RFeSP, Eno, CG31778, and Rpl37A. (E) Accumulation of transcripts in male larvae carrying roX1 (white) or 1.688 3F insertions (dark gray), and in male larvae that express ectopic 1.688 3F siRNA and have roX1 (light gray) or 1.688 3F integrations (black). Expression is normalized to dmn and wild type male larvae. SEM is derived from three biological replicates. Significance was determined using Student's two sample t-test, #0.05 (*), #0.001 (**) significance. Primers are presented in Table S1 .
involves a siRNA-directed mechanism that operates through 1.688 X repeats.
Discussion
Molecularly distinct dosage compensation strategies have arisen independently in different organisms, but a shared feature is the ability to selectively recognize and alter an entire chromosome. How a regulatory system is directed to a single chromosome is poorly understood. The discovery that 1.688 X satellite DNA promotes recruitment of dosage compensation to nearby genes supports the idea that these repeats are important for selective recognition of X chromatin (Joshi and Meller 2017) . How the 1.688 X repeats accomplish this is a question of great interest. Involvement of the siRNA pathway, and siRNA from a 1.688 X repeat, in X recognition points to the possibility that siRNA-directed modification of chromatin in and around 1.688 X repeats plays a role in dosage compensation in normal males. The findings of the current study support this idea.
Although numerous studies point to small RNA regulation of chromatin in flies, this process is better understood in other organisms (reviewed in Meller et al. 2015) . Small-RNAdirected heterochromatin formation was discovered in S. pombe (reviewed in Moazed 2009 ). Heterochromatic regions are transcribed during S phase, and transcripts are processed into siRNAs that guide the Ago1-containing RITS complex to complementary, nascent transcripts (Verdel et al. 2004) . In addition to several other activities, RITS recruits the H3K9 methyltransferase Clr4 (Zhang et al. 2008) . We propose that a similar process is occurring at 1.688 X chromatin in flies. Most 1.688 X repeats bind Ago2, and many are transcribed. Several of the 1.688 X repeats that we examined are enriched for H3K9me2 deposited by Su(var)3-9-an ortholog of Clr4. Our screen identified genetic interactions between roX1 roX2 and members of a possible RITS-like complex consisting of Ago2, Rm62 and Su(var)3-9. Finally, H3K9me2 enrichment in, and around, 1.688 X repeats is responsive to 1.688 X siRNA, and enrichment is blocked by loss of Su(var)3-9. Taken together, these findings suggest that a RITS-like complex normally modifies chromatin at 1.688 X repeats.
The idea that repressive H3K9me2 marks participate in a process culminating in a twofold increase in expression is counterintuitive, but X recognition is complex. This process involves CES sites that directly recruit the MSL complex and the 1.688 X repeats, acting indirectly to enhance X recognition ( Figure 6 ). It is possible that X recognition uses epigenetic marks, such as H3K9me2, that are distinct from the activating marks deposited within genes by the MSL complex. We propose that robust X recognition results from cooperation between two distinct pathways that guide this process. Interestingly, numerous studies have discovered links between the compensated X chromosome of male flies and repressive marks. For example, the male X is enriched in HP1, a major constituent of heterochromatin that binds H3K9me2 (de Wit et al. 2005; Liu et al. 2005) . The structure of the polytenized male X chromosome is extraordinarily sensitive to altered levels of proteins that participate in heterochromatin formation or silencing, such as HP1, Su(var)3-7, and ISWI. Mutations of these genes produce a disruption of polytenization that is strikingly specific to the male X (Deuring et al. 2000; Spierer et al. 2005; Zhang et al. 2006) . JIL-1, a kinase that enforces boundaries between heterochromatin and euchromatin, is enriched on the X chromosome and thought to participate in compensation (Jin et al. 2000; Wang et al. 2001; Ebert et al. 2004; . Upon loss of JIL-1, polytenized structure is disrupted and H3K9me2 invades euchromatic chromosome arms, but the X chromosome is most severely affected (Zhang et al. 2006) . Finally, the MSL proteins themselves have an affinity for heterochromatin. In roX1 roX2 mutant males, the MSL proteins become mislocalized to ectopic autosomal sites (Meller and Rattner 2002) . For reasons that are still unclear, the most prominent of these sites are the heterochromatic fourth chromosome and chromocenter (Deng and Meller 2006; Figueiredo et al. 2014) . Taken together, these observations suggest that X recognition, or spreading of the MSL complex, could be facilitated by repressive marks. One intriguing possibility is that 1.688 X repeats guide deposition of H3K9me2, and this mark, directly or indirectly, assists localization of the MSL complex. Although MSL-mediated compensation initiates at 3 hr AEL, before H3K9me2 enrichment over 1.688 X chromatin, male killing due to loss or mislocalization of the MSL complex occurs several days later at the larval/pupal transition. It is possible that ectopic production of 1.688 X siRNA drives enrichment of H3K9me2 across the X, supporting X recognition or MSL complex spreading at later developmental stages. This would explain why roX1 roX2 mutant male larvae, defective for X recognition, display increased X-localization of the MSL proteins and elevated viability upon expression of 1.688 X siRNA (Menon et al. 2014) . Figure 6 Proposed model of cooperative X recognition. The MSL complex is directly recruited to CES and then spreads into active genes nearby (right). 1.688 X siRNA guides an Ago2-containing complex that modifies chromatin around 1.688 X DNA, possibly in a transcription-dependent manner (left). We postulate that robust X recognition involves the cooperative action of both pathways.
An intriguing aspect of dosage compensation is the evolutionary convergence of mechanisms. For example, long noncoding RNA also plays a central role in X recognition in mammals, where expression of the X inactive specific transcript (Xist) RNA guides X inactivation (Lee 2009 ). Furthermore, repetitive LINE-1 elements that are enriched on the mammalian X chromosome are proposed to facilitate X inactivation (Lyon 1998; Bailey et al. 2000) . Some LINE-1 elements are transcribed during the onset of X inactivation, producing endo-siRNAs that may guide local spreading of heterochromatin into regions that are otherwise prone to escape (Chow et al. 2010) . These parallels are particularly striking as the outcomes, silencing of an X chromosome in mammalian females and activation of the single X in male flies, appear unrelated. We propose that cooperation between distinct chromatin-modifying systems that rely on long and short noncoding RNAs is one strategy to selectively modulate an entire chromosome.
